Growth Metrics

Evolent Health (EVH) Amortization of Deferred Charges (2017 - 2026)

Evolent Health has reported Amortization of Deferred Charges over the past 9 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 70.18% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $3.8 million, up 41.39%, while the annual FY2025 figure was $6.8 million, 41.6% up from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $2.0 million at Evolent Health, up from $106000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $8.1 million in Q4 2021 and troughed at -$12.5 million in Q4 2022.
  • A 5-year average of $653250.0 and a median of $490000.0 in 2022 define the central range for Amortization of Deferred Charges.
  • Biggest five-year swings in Amortization of Deferred Charges: skyrocketed 2400.0% in 2021 and later crashed 253.58% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $8.1 million in 2021, then crashed by 253.58% to -$12.5 million in 2022, then surged by 66.36% to -$4.2 million in 2023, then soared by 128.48% to $1.2 million in 2024, then soared by 70.18% to $2.0 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for EVH at $2.0 million in Q4 2025, $106000.0 in Q3 2025, and $441000.0 in Q2 2025.